Get the Stockscreener App
0.591
3.17%
-0.039
Tc Biopharm Holdings Plc Adr stock is traded at $0.591, with a volume of 86,936.
It is down -3.17% in the last 24 hours and down -73.13% over the past month.
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
See More
Previous Close:
$0.63
Open:
$0.6098
24h Volume:
86,936
Relative Volume:
0.07
Market Cap:
$353.79K
Revenue:
$4.60M
Net Income/Loss:
$-7.33M
P/E Ratio:
0.0127
EPS:
46.49
Net Cash Flow:
$-13.42M
1W Performance:
-5.99%
1M Performance:
-73.13%
6M Performance:
-94.74%
1Y Performance:
-99.39%
1-Day Range:
$0.5999
$0.6403
1-Week Range:
$0.5574
$0.9599
52-Week Range:
$0.5574
$138.00
Tc Biopharm Holdings Plc Adr Stock (TCBP) Company Profile
Name
Tc Biopharm Holdings Plc Adr
Sector
Industry
Phone
01414337557
Address
MAXIM 1, HOLYTOWN
Compare TCBP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| TCBP | 0.6015 | 353.79K | 4.60M | -7.33M | -13.42M | 46.49 |
| VRTX | 446.01 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 736.92 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 587.24 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.28 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.39 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Tc Biopharm Holdings Plc Adr Stock (TCBP) Latest News
TC Biopharm awarded funding of $250,000 from G-Rex Grant Program - TipRanks
TC BioPharm advances cancer therapy trials, raises $8M By Investing.com - Investing.com South Africa
TC BioPharm advances cancer therapy trials, raises $8M - Investing.com India
TC Biopharm refutes social media claim, remains compliant with Nasdaq rules - TipRanks
TC BioPharm denies Nasdaq delisting rumors - Investing.com
TC Biopharm enters research pact with Dr. Carlos Maluquer de Motes - TipRanks
TC Biopharm (Holdings) PLC – ADR trading halted, volatility trading pause - TipRanks
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80% - Investing.com
TCBP Stock Update: TC BioPharm (Holdings) plc ADR’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle
TC Biopharm announces artificial intelligene initiative with Carnegie Mellon - TipRanks
TC Biopharm announces first patient completes full dose regimen in ACHIEVE trial - TipRanks
TC BioPharm to start preclinical studies on monkeypox therapy - Investing.com India
TC Biopharm intends to launch preclinical study for treatment of Mpox - TipRanks
TC BioPharm to begin monkeypox treatment studies - Investing.com
TCBP’s Market Moves: -77.03% YTD Growth, -42.22% 6-Month loss, 68.52% in 30 Days - The InvestChronicle
TC BioPharm (Holdings) plc ADR (TCBP)’s stock rises to 7.28 per share - US Post News
TC Biopharm doses five new patients in the ACHIEVE Phase 2b trial in UK - TipRanks
TC Biopharm Unveils New Pre-Funded Warrant - TipRanks
Was there any good news for TC BioPharm (Holdings) plc ADR (TCBP) stock in the last session? - US Post News
Balance Sheet Insights: TC BioPharm (Holdings) plc ADR (TCBP)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
TC BioPharm secures European patent for cell therapy - Investing.com India
TC BioPharm Regains Nasdaq Compliance - TipRanks
TC BioPharm meets Nasdaq equity requirement - Investing.com
TC Biopharm Unveils Pre-Funded Share Warrants - TipRanks
TC BioPharm secures $2 million in direct offering - Investing.com
TC Biopharm Announces Warrant Adjustment - TipRanks
TC Biopharm At Risk of Nasdaq Delisting - TipRanks
Upcoming Stock Splits This Week (August 5 to August 9) – Stay Invested - Yahoo Finance
Apple Hospitality REIT Inc (APLE) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
TC BioPharm adjusts ADS to ordinary share ratio - Investing.com
TC BioPharm Shareholders Approve Key Resolutions - TipRanks
Is TC BioPharm (Holdings) plc ADR (TCBP) worth investing in despite its overvalued state? – US Post News - US Post News
TC BioPharm Reschedules 2024 AGM for July - TipRanks
TC Biopharm Board Members Resign Suddenly - TipRanks
A year in review: TC BioPharm (Holdings) plc ADR (TCBP)'s performance in the last year – US Post News - US Post News
TC BioPharm Announces Dr. Mike Leek as Chief Technology Officer - The Globe and Mail
TC BioPharm Announces Pricing of $5.5 Million Public Offering - The Globe and Mail
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - The Globe and Mail
TC Biopharm Announces Corporate Restructuring, Reduction in Overhead - The Globe and Mail
Market Highlights: TC BioPharm (Holdings) plc ADR (TCBP) Ends on a Low Note at 1.13 – DWinneX - The Dwinnex
TC BioPharm secures $3.1 million from warrant exercise By Investing.com - Investing.com
Amkor Technology stock rated overweight by JPMorgan, sees strong packaging demand By Investing.com - Investing.com
TC BioPharm eyes expansion with CAR-NK technology LOI - Investing.com
TC BioPharm aims to slash cancer treatment costs By Investing.com - Investing.com
Healthcare Stocks Making Moves Thursday: TCBP, DRRX, CLSD, XRTX, SPRB, IMRX, FWBI, RNXT - InvestorsObserver
symbol__ Stock Quote Price and Forecast - CNN
Healthcare Stocks Making Moves Monday: TCBP, BIAF, LXRX, GRPH, LTRN, OCEA, VTYX, SKYE - InvestorsObserver
TC BioPharm gains MHRA nod for trial amendment By Investing.com - Investing.com
TC Biopharm Plans Share Issuance, Calls Shareholder MeetingTipRanks.com - TipRanks
Healthcare Stocks Moving Up and Down Monday: RNLX, TTOO, CBAY, TLPH, ANTX, TCBP, IVVD, BDSX - InvestorsObserver
Tc Biopharm Holdings Plc Adr Stock (TCBP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.42%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):